 Thomas Jansson
Concepts (417)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta | 79 | 2023 | 637 | 17.660 |
Why?
| | Fetal Growth Retardation | 36 | 2023 | 468 | 9.060 |
Why?
| | Trophoblasts | 38 | 2023 | 168 | 8.820 |
Why?
| | TOR Serine-Threonine Kinases | 42 | 2023 | 369 | 7.780 |
Why?
| | Fetal Development | 29 | 2023 | 250 | 7.300 |
Why?
| | Pregnancy | 115 | 2023 | 5671 | 5.330 |
Why?
| | Maternal-Fetal Exchange | 22 | 2021 | 156 | 5.330 |
Why?
| | Amino Acid Transport System A | 11 | 2021 | 32 | 4.860 |
Why?
| | Diabetes, Gestational | 16 | 2023 | 284 | 4.740 |
Why?
| | Amino Acids | 21 | 2023 | 462 | 4.440 |
Why?
| | Adiponectin | 13 | 2022 | 224 | 4.250 |
Why?
| | Insulin-Like Growth Factor Binding Protein 1 | 16 | 2023 | 24 | 3.910 |
Why?
| | Pregnancy Complications | 14 | 2020 | 447 | 3.870 |
Why?
| | Insulin | 28 | 2023 | 2157 | 3.350 |
Why?
| | Insulin-Like Growth Factor I | 16 | 2023 | 285 | 3.140 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 14 | 2023 | 104 | 3.130 |
Why?
| | Glucose Intolerance | 5 | 2022 | 139 | 3.000 |
Why?
| | Maternal Nutritional Physiological Phenomena | 11 | 2021 | 157 | 2.880 |
Why?
| | Amino Acid Transport Systems | 13 | 2020 | 39 | 2.810 |
Why?
| | Obesity | 21 | 2023 | 2715 | 2.750 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 9 | 2023 | 59 | 2.690 |
Why?
| | Folic Acid | 7 | 2021 | 161 | 2.490 |
Why?
| | Fetal Macrosomia | 10 | 2023 | 56 | 2.390 |
Why?
| | Signal Transduction | 38 | 2023 | 4688 | 2.380 |
Why?
| | Birth Weight | 13 | 2021 | 463 | 2.240 |
Why?
| | Papio | 14 | 2021 | 92 | 2.210 |
Why?
| | Pregnancy Proteins | 6 | 2022 | 38 | 2.110 |
Why?
| | Amino Acid Transport System L | 5 | 2021 | 15 | 2.110 |
Why?
| | Prenatal Exposure Delayed Effects | 7 | 2022 | 465 | 1.990 |
Why?
| | Fetus | 15 | 2021 | 690 | 1.970 |
Why?
| | Placental Insufficiency | 5 | 2019 | 104 | 1.950 |
Why?
| | Female | 120 | 2023 | 61262 | 1.880 |
Why?
| | Folate Receptor 1 | 4 | 2019 | 13 | 1.800 |
Why?
| | Decidua | 7 | 2022 | 27 | 1.750 |
Why?
| | Fetal Weight | 7 | 2021 | 51 | 1.700 |
Why?
| | Cell Membrane | 11 | 2020 | 700 | 1.680 |
Why?
| | Placentation | 6 | 2021 | 42 | 1.640 |
Why?
| | Multiprotein Complexes | 6 | 2015 | 148 | 1.600 |
Why?
| | Biological Transport | 16 | 2021 | 380 | 1.600 |
Why?
| | Insulin Resistance | 9 | 2022 | 1167 | 1.580 |
Why?
| | Extracellular Vesicles | 2 | 2022 | 76 | 1.480 |
Why?
| | Glucose Transporter Type 1 | 5 | 2020 | 42 | 1.470 |
Why?
| | Folic Acid Deficiency | 3 | 2021 | 48 | 1.380 |
Why?
| | Down-Regulation | 8 | 2020 | 623 | 1.370 |
Why?
| | Animals | 57 | 2023 | 33152 | 1.320 |
Why?
| | Fetal Nutrition Disorders | 3 | 2015 | 7 | 1.320 |
Why?
| | Phosphorylation | 23 | 2023 | 1622 | 1.260 |
Why?
| | Blood Glucose | 7 | 2023 | 1936 | 1.250 |
Why?
| | Heart Diseases | 2 | 2022 | 340 | 1.200 |
Why?
| | Fatty Liver | 2 | 2022 | 247 | 1.160 |
Why?
| | Diet, Protein-Restricted | 2 | 2021 | 10 | 1.110 |
Why?
| | Pregnancy Trimester, First | 6 | 2021 | 126 | 1.090 |
Why?
| | Leucine | 7 | 2021 | 117 | 1.070 |
Why?
| | Gestational Age | 14 | 2021 | 765 | 1.060 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2021 | 810 | 1.030 |
Why?
| | Humans | 95 | 2023 | 118257 | 1.010 |
Why?
| | Adiposity | 4 | 2023 | 508 | 0.950 |
Why?
| | Cells, Cultured | 21 | 2021 | 4044 | 0.940 |
Why?
| | Symporters | 1 | 2023 | 53 | 0.940 |
Why?
| | Reduced Folate Carrier Protein | 3 | 2019 | 8 | 0.940 |
Why?
| | Pregnancy, Animal | 3 | 2014 | 57 | 0.910 |
Why?
| | Caloric Restriction | 2 | 2015 | 91 | 0.910 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 2 | 2021 | 9 | 0.900 |
Why?
| | Intracellular Signaling Peptides and Proteins | 5 | 2023 | 403 | 0.880 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2023 | 125 | 0.860 |
Why?
| | Body Mass Index | 12 | 2021 | 2074 | 0.860 |
Why?
| | Overnutrition | 1 | 2022 | 39 | 0.820 |
Why?
| | Glucose Transport Proteins, Facilitative | 2 | 2014 | 8 | 0.810 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 18 | 0.780 |
Why?
| | Liver | 6 | 2023 | 1803 | 0.780 |
Why?
| | Infant, Newborn | 19 | 2023 | 5230 | 0.780 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2020 | 15 | 0.780 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 44 | 0.780 |
Why?
| | Overweight | 3 | 2017 | 492 | 0.770 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 3 | 2021 | 274 | 0.770 |
Why?
| | Pregnancy Trimester, Second | 2 | 2020 | 70 | 0.770 |
Why?
| | Membrane Transport Proteins | 3 | 2023 | 136 | 0.770 |
Why?
| | Fatty Acid Transport Proteins | 4 | 2018 | 18 | 0.760 |
Why?
| | Lipid Metabolism | 6 | 2023 | 473 | 0.760 |
Why?
| | Serotonin | 2 | 2020 | 308 | 0.760 |
Why?
| | Food Deprivation | 3 | 2020 | 24 | 0.730 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2020 | 25 | 0.730 |
Why?
| | Leptin | 4 | 2015 | 228 | 0.720 |
Why?
| | Mice | 17 | 2023 | 15446 | 0.710 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2020 | 58 | 0.710 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 2 | 2015 | 36 | 0.670 |
Why?
| | Glucose | 10 | 2022 | 940 | 0.670 |
Why?
| | Adult | 36 | 2023 | 31325 | 0.660 |
Why?
| | Infant, Premature | 2 | 2022 | 479 | 0.650 |
Why?
| | Fatty Acid-Binding Proteins | 4 | 2018 | 62 | 0.650 |
Why?
| | Protein Kinases | 4 | 2019 | 306 | 0.650 |
Why?
| | Adaptor Proteins, Signal Transducing | 5 | 2015 | 394 | 0.640 |
Why?
| | PPAR gamma | 5 | 2022 | 187 | 0.640 |
Why?
| | Regulatory-Associated Protein of mTOR | 6 | 2019 | 19 | 0.630 |
Why?
| | Fusion Regulatory Protein 1, Light Chains | 2 | 2015 | 6 | 0.630 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2015 | 147 | 0.620 |
Why?
| | Mice, Obese | 4 | 2022 | 57 | 0.610 |
Why?
| | Fatty Acids, Unsaturated | 4 | 2018 | 86 | 0.610 |
Why?
| | Casein Kinase II | 7 | 2021 | 21 | 0.610 |
Why?
| | Specimen Handling | 1 | 2018 | 163 | 0.610 |
Why?
| | Metabolic Diseases | 1 | 2018 | 103 | 0.600 |
Why?
| | Mice, Inbred C57BL | 10 | 2020 | 4887 | 0.600 |
Why?
| | Organ Size | 8 | 2021 | 460 | 0.590 |
Why?
| | RNA Interference | 5 | 2021 | 459 | 0.590 |
Why?
| | Disease Models, Animal | 9 | 2022 | 3676 | 0.580 |
Why?
| | Transcriptome | 3 | 2022 | 752 | 0.570 |
Why?
| | Homeostasis | 1 | 2020 | 589 | 0.560 |
Why?
| | AMP-Activated Protein Kinases | 5 | 2022 | 179 | 0.550 |
Why?
| | Hormones | 2 | 2008 | 135 | 0.550 |
Why?
| | Chorionic Villi | 4 | 2019 | 16 | 0.550 |
Why?
| | Altitude | 1 | 2019 | 422 | 0.540 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 5 | 2015 | 66 | 0.520 |
Why?
| | Docosahexaenoic Acids | 4 | 2023 | 70 | 0.520 |
Why?
| | Proteome | 1 | 2018 | 349 | 0.510 |
Why?
| | RNA, Small Interfering | 6 | 2023 | 562 | 0.510 |
Why?
| | Rapamycin-Insensitive Companion of mTOR Protein | 5 | 2019 | 28 | 0.500 |
Why?
| | Weight Gain | 2 | 2015 | 485 | 0.490 |
Why?
| | Homocysteine | 2 | 2017 | 137 | 0.480 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2013 | 23 | 0.470 |
Why?
| | Ubiquitination | 3 | 2022 | 86 | 0.470 |
Why?
| | Vitamin D | 1 | 2016 | 352 | 0.460 |
Why?
| | Nutritional Status | 1 | 2015 | 298 | 0.450 |
Why?
| | Diet, High-Fat | 4 | 2022 | 247 | 0.450 |
Why?
| | Proton-Coupled Folate Transporter | 3 | 2019 | 8 | 0.430 |
Why?
| | Primary Cell Culture | 6 | 2019 | 154 | 0.430 |
Why?
| | Placental Circulation | 6 | 2019 | 56 | 0.430 |
Why?
| | Gene Expression Regulation | 5 | 2021 | 2435 | 0.430 |
Why?
| | Fatty Acids | 5 | 2022 | 403 | 0.430 |
Why?
| | Pregnancy in Diabetics | 3 | 2021 | 88 | 0.430 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 1795 | 0.420 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 3 | 2016 | 13 | 0.420 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2022 | 418 | 0.410 |
Why?
| | Male | 24 | 2023 | 57476 | 0.410 |
Why?
| | Case-Control Studies | 5 | 2021 | 3156 | 0.390 |
Why?
| | Microvilli | 4 | 2019 | 70 | 0.390 |
Why?
| | PPAR alpha | 4 | 2015 | 55 | 0.380 |
Why?
| | Biological Availability | 2 | 2023 | 126 | 0.370 |
Why?
| | STAT3 Transcription Factor | 2 | 2014 | 186 | 0.370 |
Why?
| | Cohort Studies | 6 | 2023 | 5078 | 0.370 |
Why?
| | Oleic Acid | 3 | 2014 | 34 | 0.360 |
Why?
| | Hypoxia | 3 | 2022 | 957 | 0.360 |
Why?
| | Dietary Proteins | 1 | 2011 | 131 | 0.360 |
Why?
| | Ion Transport | 1 | 2009 | 59 | 0.350 |
Why?
| | Carrier Proteins | 5 | 2021 | 725 | 0.350 |
Why?
| | Dietary Fats | 2 | 2008 | 323 | 0.350 |
Why?
| | Rats, Wistar | 8 | 2021 | 396 | 0.340 |
Why?
| | Fetal Blood | 3 | 2023 | 270 | 0.340 |
Why?
| | Receptors, Adiponectin | 3 | 2019 | 14 | 0.330 |
Why?
| | beta-Alanine | 2 | 2006 | 20 | 0.330 |
Why?
| | Proteolysis | 2 | 2022 | 146 | 0.330 |
Why?
| | Rats | 10 | 2021 | 5339 | 0.330 |
Why?
| | In Vitro Techniques | 5 | 2021 | 1082 | 0.320 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 2 | 2023 | 16 | 0.310 |
Why?
| | Amino Acid Transport Systems, Neutral | 1 | 2007 | 5 | 0.300 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2020 | 96 | 0.300 |
Why?
| | Food | 1 | 2009 | 162 | 0.300 |
Why?
| | Malaria, Falciparum | 2 | 2017 | 31 | 0.300 |
Why?
| | Hypoglycemic Agents | 3 | 2019 | 1031 | 0.290 |
Why?
| | RNA, Messenger | 5 | 2023 | 2657 | 0.290 |
Why?
| | Hyperglycemia | 2 | 2007 | 313 | 0.290 |
Why?
| | Taurine | 1 | 2007 | 46 | 0.290 |
Why?
| | Protein Transport | 3 | 2021 | 407 | 0.280 |
Why?
| | Biological Transport, Active | 3 | 2015 | 73 | 0.280 |
Why?
| | Cesarean Section | 2 | 2022 | 165 | 0.280 |
Why?
| | DNA Methylation | 2 | 2023 | 501 | 0.280 |
Why?
| | CD36 Antigens | 2 | 2016 | 40 | 0.270 |
Why?
| | Up-Regulation | 3 | 2015 | 862 | 0.270 |
Why?
| | Hep G2 Cells | 7 | 2021 | 73 | 0.270 |
Why?
| | Energy Intake | 1 | 2008 | 445 | 0.260 |
Why?
| | Gene Knockdown Techniques | 3 | 2021 | 312 | 0.260 |
Why?
| | Chromatography, Liquid | 2 | 2023 | 353 | 0.260 |
Why?
| | Palmitic Acid | 2 | 2014 | 38 | 0.250 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2004 | 46 | 0.250 |
Why?
| | Cell Hypoxia | 3 | 2021 | 217 | 0.250 |
Why?
| | Protein Kinase C-alpha | 2 | 2021 | 43 | 0.250 |
Why?
| | Tandem Mass Spectrometry | 2 | 2023 | 418 | 0.250 |
Why?
| | Phospholipids | 2 | 2023 | 207 | 0.240 |
Why?
| | Gene Silencing | 4 | 2021 | 177 | 0.240 |
Why?
| | Young Adult | 8 | 2021 | 10731 | 0.240 |
Why?
| | Maternal Age | 3 | 2021 | 122 | 0.240 |
Why?
| | Amino Acids, Essential | 1 | 2023 | 12 | 0.240 |
Why?
| | Term Birth | 2 | 2015 | 17 | 0.230 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2022 | 141 | 0.230 |
Why?
| | Umbilical Veins | 2 | 2014 | 58 | 0.220 |
Why?
| | Embryonic Development | 2 | 2021 | 117 | 0.220 |
Why?
| | Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 15 | 0.220 |
Why?
| | Adult Children | 1 | 2022 | 18 | 0.210 |
Why?
| | Fetal Heart | 1 | 2022 | 29 | 0.210 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2023 | 103 | 0.210 |
Why?
| | 3T3-L1 Cells | 1 | 2022 | 35 | 0.210 |
Why?
| | Body Weight | 3 | 2012 | 923 | 0.210 |
Why?
| | Carnitine | 1 | 2022 | 65 | 0.210 |
Why?
| | Sirolimus | 5 | 2020 | 195 | 0.210 |
Why?
| | Animals, Newborn | 2 | 2018 | 804 | 0.200 |
Why?
| | Inflammation Mediators | 2 | 2015 | 497 | 0.200 |
Why?
| | Glucose Tolerance Test | 1 | 2022 | 361 | 0.200 |
Why?
| | Intra-Abdominal Fat | 1 | 2022 | 89 | 0.200 |
Why?
| | Cardiomegaly | 1 | 2022 | 167 | 0.200 |
Why?
| | Infant, Low Birth Weight | 2 | 2019 | 125 | 0.190 |
Why?
| | Monoamine Oxidase | 1 | 2020 | 25 | 0.190 |
Why?
| | Testosterone | 2 | 2016 | 350 | 0.190 |
Why?
| | Triglycerides | 4 | 2023 | 515 | 0.190 |
Why?
| | Organogenesis | 1 | 2021 | 54 | 0.190 |
Why?
| | Umbilical Cord | 1 | 2020 | 84 | 0.190 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2022 | 341 | 0.190 |
Why?
| | Embryo, Mammalian | 1 | 2021 | 219 | 0.190 |
Why?
| | Skinfold Thickness | 1 | 2020 | 46 | 0.190 |
Why?
| | Cell Culture Techniques | 2 | 2021 | 354 | 0.190 |
Why?
| | Adipocytes | 1 | 2022 | 195 | 0.180 |
Why?
| | Myometrium | 1 | 2019 | 35 | 0.170 |
Why?
| | Biomarkers | 3 | 2022 | 3568 | 0.170 |
Why?
| | Organelle Biogenesis | 1 | 2019 | 15 | 0.170 |
Why?
| | Infant | 3 | 2023 | 8254 | 0.170 |
Why?
| | Immunohistochemistry | 3 | 2018 | 1681 | 0.170 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2019 | 48 | 0.170 |
Why?
| | Myoblasts, Skeletal | 1 | 2018 | 11 | 0.170 |
Why?
| | Electron Transport | 1 | 2019 | 101 | 0.170 |
Why?
| | Lysophosphatidylcholines | 1 | 2018 | 26 | 0.170 |
Why?
| | Olive Oil | 1 | 2018 | 4 | 0.170 |
Why?
| | Enzyme Activation | 3 | 2015 | 810 | 0.170 |
Why?
| | Protein Interaction Maps | 1 | 2018 | 36 | 0.170 |
Why?
| | Protein Kinase C | 2 | 2021 | 294 | 0.160 |
Why?
| | PPAR delta | 1 | 2018 | 6 | 0.160 |
Why?
| | Tetrahydrofolates | 1 | 2018 | 11 | 0.160 |
Why?
| | Child, Preschool | 3 | 2023 | 9448 | 0.160 |
Why?
| | Lipids | 1 | 2022 | 591 | 0.160 |
Why?
| | Oxidative Phosphorylation | 1 | 2019 | 156 | 0.160 |
Why?
| | Models, Biological | 4 | 2021 | 1701 | 0.160 |
Why?
| | Piperidines | 1 | 2019 | 171 | 0.160 |
Why?
| | Blood Platelets | 1 | 2020 | 344 | 0.160 |
Why?
| | Exosomes | 1 | 2018 | 92 | 0.150 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2017 | 24 | 0.150 |
Why?
| | alpha-Linolenic Acid | 1 | 2017 | 8 | 0.150 |
Why?
| | Glyburide | 1 | 2017 | 36 | 0.150 |
Why?
| | Mice, Inbred ICR | 1 | 2017 | 111 | 0.150 |
Why?
| | Rats, Sprague-Dawley | 3 | 2007 | 2434 | 0.150 |
Why?
| | Protein Processing, Post-Translational | 3 | 2015 | 408 | 0.150 |
Why?
| | Arachidonic Acid | 1 | 2017 | 117 | 0.150 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2017 | 10 | 0.150 |
Why?
| | Phosphoproteins | 2 | 2011 | 303 | 0.150 |
Why?
| | Prospective Studies | 2 | 2021 | 6443 | 0.140 |
Why?
| | Muscle Contraction | 1 | 2019 | 413 | 0.140 |
Why?
| | Electroacupuncture | 1 | 2016 | 2 | 0.140 |
Why?
| | Receptors, Calcitriol | 1 | 2016 | 56 | 0.140 |
Why?
| | Cholecalciferol | 1 | 2016 | 49 | 0.140 |
Why?
| | Resource Allocation | 1 | 2016 | 38 | 0.140 |
Why?
| | Echocardiography | 1 | 2019 | 556 | 0.140 |
Why?
| | Proteomics | 1 | 2022 | 850 | 0.140 |
Why?
| | Coenzyme A Ligases | 1 | 2016 | 11 | 0.140 |
Why?
| | Pediatric Obesity | 1 | 2023 | 512 | 0.140 |
Why?
| | Amino Acid Transport System y+L | 1 | 2015 | 4 | 0.140 |
Why?
| | Fatty Acid Binding Protein 3 | 1 | 2015 | 4 | 0.140 |
Why?
| | Caspase 3 | 2 | 2014 | 240 | 0.140 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2015 | 13 | 0.140 |
Why?
| | Androgens | 1 | 2017 | 167 | 0.140 |
Why?
| | Excitatory Amino Acids | 1 | 2015 | 7 | 0.140 |
Why?
| | Diet | 3 | 2022 | 1143 | 0.140 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2017 | 227 | 0.130 |
Why?
| | Transport Vesicles | 1 | 2015 | 19 | 0.130 |
Why?
| | Dietary Sucrose | 1 | 2015 | 55 | 0.130 |
Why?
| | Hepatocytes | 2 | 2014 | 204 | 0.130 |
Why?
| | Lipase | 1 | 2015 | 67 | 0.130 |
Why?
| | Anti-Inflammatory Agents | 1 | 2019 | 466 | 0.130 |
Why?
| | Heart | 1 | 2019 | 630 | 0.130 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2015 | 139 | 0.130 |
Why?
| | Child | 4 | 2023 | 19033 | 0.130 |
Why?
| | Interleukin-1beta | 2 | 2014 | 377 | 0.120 |
Why?
| | Ovarian Neoplasms | 1 | 2019 | 420 | 0.120 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2021 | 2159 | 0.120 |
Why?
| | Autophagy | 1 | 2017 | 312 | 0.120 |
Why?
| | bcl-2-Associated X Protein | 1 | 2013 | 46 | 0.120 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2017 | 296 | 0.120 |
Why?
| | Myocardium | 1 | 2019 | 965 | 0.120 |
Why?
| | Analysis of Variance | 2 | 2017 | 1288 | 0.120 |
Why?
| | Ceramides | 1 | 2014 | 96 | 0.110 |
Why?
| | Transfection | 1 | 2015 | 887 | 0.110 |
Why?
| | Liver Neoplasms | 1 | 2017 | 526 | 0.110 |
Why?
| | Receptor, IGF Type 1 | 3 | 2021 | 59 | 0.110 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2013 | 32 | 0.110 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2491 | 0.110 |
Why?
| | Mitochondria | 1 | 2019 | 785 | 0.110 |
Why?
| | Energy Metabolism | 2 | 2015 | 762 | 0.110 |
Why?
| | Blood Urea Nitrogen | 1 | 2012 | 59 | 0.110 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1515 | 0.110 |
Why?
| | Hyperandrogenism | 1 | 2012 | 14 | 0.110 |
Why?
| | Protein Subunits | 1 | 2013 | 210 | 0.110 |
Why?
| | Oxygen | 1 | 2017 | 854 | 0.110 |
Why?
| | Apoptosis | 2 | 2019 | 2461 | 0.110 |
Why?
| | MicroRNAs | 1 | 2018 | 633 | 0.110 |
Why?
| | Brain | 1 | 2023 | 2481 | 0.100 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2011 | 21 | 0.100 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2012 | 162 | 0.100 |
Why?
| | Prognosis | 1 | 2019 | 3424 | 0.100 |
Why?
| | Phosphatidylcholines | 2 | 2023 | 131 | 0.100 |
Why?
| | Colorado | 1 | 2020 | 4178 | 0.090 |
Why?
| | Mothers | 1 | 2015 | 675 | 0.090 |
Why?
| | Stromal Cells | 2 | 2021 | 100 | 0.090 |
Why?
| | Glucocorticoids | 1 | 2013 | 545 | 0.080 |
Why?
| | Inflammation | 2 | 2022 | 2545 | 0.080 |
Why?
| | Pregnancy Trimester, Third | 1 | 2008 | 69 | 0.080 |
Why?
| | Immunity, Innate | 1 | 2014 | 744 | 0.080 |
Why?
| | Microscopy, Fluorescence | 2 | 2021 | 410 | 0.080 |
Why?
| | Sex Factors | 1 | 2013 | 1765 | 0.080 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenases | 1 | 2007 | 3 | 0.080 |
Why?
| | Glucose Transporter Type 3 | 1 | 2007 | 11 | 0.080 |
Why?
| | Amino Acid Transport System y+ | 1 | 2007 | 5 | 0.080 |
Why?
| | Sex Characteristics | 2 | 2023 | 667 | 0.080 |
Why?
| | Hyperlipoproteinemia Type I | 1 | 2007 | 7 | 0.070 |
Why?
| | Uterus | 2 | 2019 | 197 | 0.070 |
Why?
| | Fluorescent Antibody Technique | 2 | 2018 | 409 | 0.070 |
Why?
| | Oxidative Stress | 2 | 2018 | 1167 | 0.070 |
Why?
| | Lipoprotein Lipase | 1 | 2007 | 62 | 0.070 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2006 | 22 | 0.070 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2018 | 211 | 0.070 |
Why?
| | Glucose Clamp Technique | 1 | 2007 | 194 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2013 | 2855 | 0.070 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 4522 | 0.070 |
Why?
| | Interviews as Topic | 1 | 2008 | 593 | 0.070 |
Why?
| | Mass Spectrometry | 2 | 2021 | 670 | 0.070 |
Why?
| | Lactic Acid | 1 | 2006 | 278 | 0.060 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2017 | 156 | 0.060 |
Why?
| | Osmolar Concentration | 1 | 2004 | 181 | 0.060 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2004 | 196 | 0.060 |
Why?
| | Dietary Supplements | 2 | 2018 | 468 | 0.060 |
Why?
| | Microscopy, Electron | 1 | 2004 | 412 | 0.060 |
Why?
| | Ether | 1 | 2023 | 7 | 0.060 |
Why?
| | Ethyl Ethers | 1 | 2023 | 4 | 0.060 |
Why?
| | Plasmalogens | 1 | 2023 | 6 | 0.060 |
Why?
| | Ethers | 1 | 2023 | 17 | 0.060 |
Why?
| | Electrolytes | 1 | 2003 | 59 | 0.060 |
Why?
| | Phosphatidylethanolamines | 1 | 2023 | 66 | 0.060 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 2014 | 155 | 0.060 |
Why?
| | Cell Cycle Proteins | 1 | 2007 | 563 | 0.060 |
Why?
| | Body Composition | 1 | 2007 | 644 | 0.050 |
Why?
| | Pregnancy, High-Risk | 1 | 2002 | 12 | 0.050 |
Why?
| | Adipose Tissue | 1 | 2007 | 595 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 1937 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2006 | 685 | 0.050 |
Why?
| | Insulin, Regular, Human | 1 | 2022 | 32 | 0.050 |
Why?
| | MAP Kinase Signaling System | 2 | 2014 | 284 | 0.050 |
Why?
| | Insulin Receptor Substrate Proteins | 2 | 2013 | 59 | 0.050 |
Why?
| | Pregnant Women | 1 | 2023 | 132 | 0.050 |
Why?
| | Maleimides | 1 | 2021 | 22 | 0.050 |
Why?
| | Cell Shape | 1 | 2021 | 57 | 0.050 |
Why?
| | Norway | 1 | 2021 | 35 | 0.050 |
Why?
| | Receptors, Erythropoietin | 1 | 2021 | 25 | 0.050 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2021 | 153 | 0.050 |
Why?
| | Cholesterol | 1 | 2023 | 375 | 0.050 |
Why?
| | Epithelial Cells | 1 | 2007 | 951 | 0.050 |
Why?
| | Esterification | 1 | 2020 | 15 | 0.050 |
Why?
| | Parity | 1 | 2021 | 100 | 0.050 |
Why?
| | Erythropoietin | 1 | 2021 | 82 | 0.050 |
Why?
| | Reference Values | 1 | 2002 | 770 | 0.050 |
Why?
| | Receptors, Amino Acid | 1 | 2020 | 25 | 0.050 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 244 | 0.040 |
Why?
| | NF-kappa B | 2 | 2014 | 664 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 817 | 0.040 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2019 | 24 | 0.040 |
Why?
| | Cell Cycle Checkpoints | 1 | 2019 | 87 | 0.040 |
Why?
| | Adolescent | 3 | 2019 | 18364 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2020 | 158 | 0.040 |
Why?
| | Indoles | 1 | 2021 | 311 | 0.040 |
Why?
| | Sodium | 1 | 2020 | 200 | 0.040 |
Why?
| | Arachidonic Acids | 1 | 2018 | 57 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 160 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2021 | 523 | 0.040 |
Why?
| | Neoplasm Grading | 1 | 2019 | 257 | 0.040 |
Why?
| | Mitosis | 1 | 2019 | 172 | 0.040 |
Why?
| | Perilipin-2 | 1 | 2018 | 36 | 0.040 |
Why?
| | Phagosomes | 1 | 2017 | 43 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 935 | 0.040 |
Why?
| | Sheep | 1 | 2020 | 762 | 0.040 |
Why?
| | Lipogenesis | 1 | 2017 | 66 | 0.040 |
Why?
| | Lysosomes | 1 | 2017 | 135 | 0.040 |
Why?
| | Phosphoserine | 1 | 2015 | 34 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1469 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2015 | 156 | 0.030 |
Why?
| | Blotting, Western | 2 | 2010 | 1186 | 0.030 |
Why?
| | Adenylate Kinase | 1 | 2014 | 29 | 0.030 |
Why?
| | Corticosterone | 1 | 2016 | 253 | 0.030 |
Why?
| | Caspase 10 | 1 | 2014 | 5 | 0.030 |
Why?
| | Chorionic Gonadotropin | 1 | 2014 | 80 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 888 | 0.030 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2014 | 104 | 0.030 |
Why?
| | Time Factors | 1 | 2004 | 6368 | 0.030 |
Why?
| | GRB2 Adaptor Protein | 1 | 2013 | 12 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2014 | 98 | 0.030 |
Why?
| | Transcription Factors | 1 | 2021 | 1567 | 0.030 |
Why?
| | Incidence | 1 | 2019 | 2413 | 0.030 |
Why?
| | Transgenes | 1 | 2014 | 174 | 0.030 |
Why?
| | Estradiol Dehydrogenases | 1 | 2012 | 1 | 0.030 |
Why?
| | Estrous Cycle | 1 | 2012 | 17 | 0.030 |
Why?
| | Binding Sites | 1 | 2015 | 1221 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2013 | 175 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 2837 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2019 | 2262 | 0.030 |
Why?
| | Random Allocation | 1 | 2012 | 344 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2063 | 0.030 |
Why?
| | Receptors, Androgen | 1 | 2012 | 132 | 0.020 |
Why?
| | Dexamethasone | 1 | 2013 | 319 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2855 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 330 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2012 | 386 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1045 | 0.020 |
Why?
| | Blood Pressure | 1 | 2016 | 1656 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 27511 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1482 | 0.020 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2007 | 31 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1004 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2006 | 45 | 0.020 |
Why?
| | Amniotic Fluid | 1 | 2006 | 68 | 0.020 |
Why?
| | Protons | 1 | 2006 | 78 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 1880 | 0.020 |
Why?
| | Permeability | 1 | 2006 | 154 | 0.020 |
Why?
| | Ultrasonography, Prenatal | 1 | 2006 | 227 | 0.020 |
Why?
| | Muscle Proteins | 1 | 2006 | 218 | 0.020 |
Why?
| | Phenotype | 1 | 2005 | 2937 | 0.010 |
Why?
|
|
Jansson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|